Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

NCT06973499 is registered in ClinicalTrials.gov with Beijing Haidian Hospital as lead sponsor.

NCT NCT06973499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06973499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer
Lead sponsor
Beijing Haidian Hospital
Phase
Observational
Overall status
Completed
Start date
January 6, 2023
Completion date
December 25, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microbial colonization, multiple primary lung cancer